See what questions
a doctor would ask.
Positive clinical trial results have made it likely that the FDA will approve a new inhalation treatment drug for pulmonary arterial hypertension. The drug is called Ventavis or prostacyclin. It is intended for patients where oral medications have failed to control the condition. Other pharmaceutical companies are already developing their own alternative treatments.
Source: summary of medical news story as reported by Forbes - Associated Press
About: Company seeks FDA approval for new drug to treat pulmonary arterial hypertension
Date: 30 November 2004
Source: Forbes - Associated Press
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City